SUNSHINE BIOPHARMA, INC. ANNOUNCES PRICING OF $8.0 MILLION PRIVATE[...]
SUNSHINE BIOPHARMA, INC. ANNOUNCES CLOSING OF $8.0 MILLION PRIVATE[...]
SUNSHINE BIOPHARMA’S NEWLY DESIGNED MRNA MOLECULES PROVE EFFECTIVE[...]
04/25/2022 | Press release | Archived content
Please select the service you want to use:
Smartlinks | Sunshine Biopharma Inc. | News | Health | Science | Research | Company News | Top Company News | Business Announcement | Products and Services | Patent | Pharmaceuticals | Securities Issuers | Pharmaceutical Companies | NYSE American | NYSE ARCA Equities | Nasdaq Capital Market | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | FINRA Alternative Display Facility (ADF) | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact